0

No products in the cart.

0

No products in the cart.

Home Business Sagimet Biosciences director George Kemble sells $201,146 in shares
Business

Sagimet Biosciences director George Kemble sells $201,146 in shares

Updated 57 minutes Ago1 Mins read0 Views
Share
Sagimet Biosciences director George Kemble sells 1,146 in shares
Share


Sagimet Biosciences director George Kemble sells $201,146 in shares

Source link

Share
Australia central banker says rate hikes working as intended Previous post Australia central banker says rate hikes working as intended

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Orora FY26 slides: cans surge offsets glass impairment of A3m
Business

Orora FY26 slides: cans surge offsets glass impairment of A$743m

3 minutes Ago
Earnings call transcript: NANO Nuclear beats Q3 2026 EPS forecast, shares edge up
Business

Earnings call transcript: MFF Group posts strong H2 2026 profit, lifts dividend plans

13 minutes Ago
Earnings call transcript: Telstra H2 2026 profit rises, shares fall 4%
Business

Earnings call transcript: Telstra H2 2026 profit rises, shares fall 4%

25 minutes Ago
Treasury Wine FY 2026 slides: EBITS ahead, major US restructuring
Business

Treasury Wine FY 2026 slides: EBITS ahead, major US restructuring

36 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com